With its new serum, the medical grade skin care brand is targeting laxity, which many weight loss drug users experience.

USA: A new study published in JAMA Network Open suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs) may offer ...

Innovent likely to post a first-half net profit of US$36.4 illion, and BeOne’s first-half net rofit is expected to come in at ...

GLP-1 medications like Ozempic, Wegovy, and Mounjaro are changing the weight loss game. But there’s a catch—and most people don’t hear about it until it’s too late. Yes, these medications suppress ...

Glucagon-like peptide-1 (GLP-1) inhibitors have proven effective in preventing cardiovascular events, leading to experts ...

If you have cash to invest in the stock market right now, and you're looking for growth stocks that could make smart additions to the basket of businesses you own, there are names ...

Byproducts from gut bacteria breaking down tryptophan, a dietary amino acid, can restore hormone-secreting gut cells reduced ...

If you're looking to put cash into two fantastic biotech stocks that Wall Street seems particularly bullish on, there's one ...

Redditors have complained Ozempic has caused them to lose their libido, resulting in less time spent self-pleasuring.

Guardian Australia has uncovered a new scam targeting people who are trying to lose weight. Crooks pose as famous dietitians ...

New fat-busting drugs are helping public employees lose weight, but they're also busting budgets for local governments.